A probiotic strain produced by BioGaia (Raleigh, NC) has demonstrated a substantially reduced frequency of regurgitation in infants.
A probiotic strain produced by BioGaia (Raleigh, NC) has demonstrated a substantially reduced frequency of regurgitation in infants, according to research published in the European Journal of Clinical Investigation.
The probiotic specialist announced the news as supporting a previous trial on its Lactobacillus reuteri Protectis strain against uncomplicated infant regurgitation.
In the double-blind, placebo-controlled study, 42 formula-fed infants under four months of age were assigned to daily supplementation of placebo or the probiotic for 30 days. Incidence of regurgitate was reduced by 80% in the probiotic group compared to 33% in the placebo group. During the final week, regurgitation was reduced by an average 75% with probiotic compared to placebo.
“Uncomplicated regurgitation is common among infants and we are convinced that these exciting results with L. reuteri will have an impact on future handling of infants with persistent regurgitation,” said study author Flavia Indrio of the University of Bari (Italy) department of pediatrics.
Check out the study’s abtract here.